Sign in
4

Changes in Ownership

Tango Therapeutics, Inc. Filed Acc 0000899243-22-024398

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rothenberg Mace · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-06-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +40,000 $5.90 2032-06-08 40,000 40,000 D
Loading xslF345X03/doc4.xml…